0001213900-19-011860.txt : 20190701
0001213900-19-011860.hdr.sgml : 20190701
20190701160534
ACCESSION NUMBER: 0001213900-19-011860
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190701
FILED AS OF DATE: 20190701
DATE AS OF CHANGE: 20190701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hochman David P
CENTRAL INDEX KEY: 0001292834
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38389
FILM NUMBER: 19933241
MAIL ADDRESS:
STREET 1: 15 WESTON HILL RD.
CITY: RIVERSIDE
STATE: CT
ZIP: 06878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Motus GI Holdings, Inc.
CENTRAL INDEX KEY: 0001686850
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 814042793
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1301 EAST BROWARD BOULEVARD
STREET 2: 3RD FLOOR
CITY: FT. LAUDERDALE
STATE: FL
ZIP: 33301
BUSINESS PHONE: 786-459-1831
MAIL ADDRESS:
STREET 1: 1301 EAST BROWARD BOULEVARD
STREET 2: 3RD FLOOR
CITY: FT. LAUDERDALE
STATE: FL
ZIP: 33301
FORMER COMPANY:
FORMER CONFORMED NAME: Eight-Ten Merger Corp.
DATE OF NAME CHANGE: 20161006
4
1
ownership.xml
X0306
4
2019-07-01
0
0001686850
Motus GI Holdings, Inc.
MOTS
0001292834
Hochman David P
C/O MOTUS GI HOLDINGS, INC.
1301 EAST BROWARD BOULEVARD, 3RD FLOOR
FT. LAUDERDALE
FL
33301
1
0
0
1
Chairman of the Board
Common Stock, par value $0.0001 per share
18000
D
Common Stock, par value $0.0001 per share
109792
I
By Orchestra Medical Ventures II, L.P.
Common Stock, par value $0.0001 per share
2000000
I
By Orchestra BioMed, Inc.
Common Stock, par value $0.0001 per share
1159968
I
By Orchestra MOTUS Co-Investment Partners, LLC
Common Stock, par value $0.0001 per share
83352
I
By Orchestra Medical Ventures II Reserve, L.P.
Common Stock, par value $0.0001 per share
51498
I
By Accelerated Technologies, Inc.
Common Stock, par value $0.0001 per share
2019-07-01
4
P
0
10000
3.00
A
110000
I
By DPH 2008 Trust
The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on July 1, 2019.
The securities are directly held by Orchestra Medical Ventures II, L.P. ("OMV II"). Orchestra Medical Ventures II GP, LLC ("OMV GP") serves as general partner to OMV II. Reporting Person and Darren Sherman are the managing members of OMV GP. Reporting Person and Mr. Sherman jointly exercise dispositive and voting power over the shares owned by OMV II. Each of Reporting Person, Mr. Sherman and OMV GP disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
The securities are directly held by Orchestra BioMed, Inc., a Delaware corporation ("OBIO"). Reporting Person, Mr. Sherman and Geoffrey W. Smith are the directors of OBIO. Reporting Person, Mr. Sherman and Mr. Smith jointly exercise dispositive and voting power over the shares owned by OBIO. Each of Reporting Person, Mr. Sherman and Mr. Smith disclaim, for purposes of Section 16, beneficial ownership of such securities, except to the extent of their indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or Mr. Smith are the beneficial owners of such securities for purposes of Section 16 or for any other purposes.
The securities are directly held by Orchestra MOTUS Co-Investment Partners, LLC ("OMCP"). Orchestra Medical Ventures, LLC ("OMV LLC") serves as managing member to OMCP. Reporting Person and Mr. Sherman are the managing partners of OMV LLC. Reporting Person and Mr. Sherman jointly exercise dispositive and voting power over the shares owned by OMCP. Each of Reporting Person, Mr. Sherman and OMV LLC disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV LLC is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
The securities are directly held by Orchestra Medical Ventures II Reserve, L.P. ("OMV Reserve"). OMV GP serves as general partner to OMV Reserve. Reporting Person and Mr. Sherman are the managing members of OMV GP. Reporting Person and Mr. Sherman jointly exercise dispositive and voting power over the shares owned by OMV Reserve. Each of Reporting Person, Mr. Sherman and OMV GP disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
The securities are directly held by Accelerated Technologies, Inc. ("ATI"). Reporting Person and Mr. Sherman jointly exercise dispositive and voting power over the shares owned by ATI. Each of Reporting Person and Mr. Sherman disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person or Mr. Sherman is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
/s/ Andrew Taylor, power of attorney
2019-07-01